Order Now - Just $149.95 For Full Access - 3 CME Credits
Communication 101: 
A Video Approach to Help Clinicians 
Rapidly Convey Key Clinical Messages to Patients with Disorders of Gut-Brain Interaction (DGBI) 
A DrossmanCare and Rome Foundation Educational Product

Author, Publisher and Director
Douglas A. Drossman, MD

Videography and Editing
DrossmanCare created and produced this video program in collaboration with Davis Stillson Associates, who provided the technical production, and the Rome Foundation, who provided the marketing and distribution.
1
Your Personal Info
Please use your CC billing address
2
your info
Your Billing Info
Shipping
We Respect Your Privacy & Information
Communication 101: A Video Approach to Help Clinicians Rapidly Convey Key Clinical Messages to Patients with Disorders of Gut-Brain Interaction (DGBI)

Communication 101 is an innovative video learning tool for clinicians who work with patients having Disorders of Gut-Brain Interaction (Functional GI Disorders). This program leverages the expertise of 15 thought leaders in neurogastroenterology to demonstrate how they educate patients with DGBIs on the most common clinical issues that arise in the course of a clinical visit. 

After reviewing this program, you will be able to:
● Help your patient quickly understand their symptoms, disorders and proper treatments
● Cover a wide variety of complex topics clearly, thoroughly and concisely
● Maximize the likelihood that your patients will be satisfied knowing what they have and how they will be treated

Included in this program are 32 educational discussions, covering 11 content categories. Some of the topics may seem difficult to explain to a patient. Therefore, our experts approach each video demonstration with full knowledge of the content and provide the clinical expertise to interpret the information clearly and concisely using practical communication methods. The interviews are brief, only 3-8 minutes, and include a detailed written statement describing what was said and why. For some topics, more than one clinician demonstrates their approach so the learner can select which method best fits their style. 

Anti-Diarrheal Treatments
    • Dr. Cash: How to Explain Antidiarrheal Treatments
    • Dr. Lucak: How to Explain Treatments for IBS with Diarrhea

Behavioral Treatments
    • Dr. Keefer How to Explain Hypnotherapy and Cognitive Behavioral Therapy for IBS-M
    • Dr. Keefer: How to Explain Psychotherapy Options to a Reluctant Patient
    • Dr. Kinsinger: How to Explain Hypnotherapy and Cognitive Behavioral Therapy
    • Dr. Tack: How to Explain Referral for Psychological Treatment

Using Central Neuromodulators
    • Dr. Halpert: How to Explain the Use of Neuromodulators 
    • Dr. Sayuk: How to Explain the Use of Central Neuromodulators (Antidepressants) for Abdominal Pain
    • Dr. Tack: How to Explain the Use of Neuromodulators to a Patient with CAPS Seeking Opioids

Explaining Constipation and Pelvic Floor Dysfunction
    • Dr. Harris: How to Explain Dyssynergic Defecation (Pelvic Floor Dysfunction)
    • Dr. Lucak: How to Explain Chronic Constipation

Diet
    • Dr. Chey: How to Explain a Low FODMAP Diet    
    • Dr. Harris: How to Explain a Low FODMAP Diet
    • Dr. Kinsinger: How to Re-Educate Patients Who Over-Restrict Their Diet
    • Dr. Lacy: How to Explain a Low FODMAP Diet

Explaining Common Diagnoses
    • Dr. Cash: How to Explain Opioid Induced Constipation
    • Dr. Chey: How to Explain Functional Dyspepsia
    • Dr. Sayuk: How to Address Patients Who Demand Narcotic
    • Dr. Simren: How to Explain Irritable Bowel Syndrome

Explaining the Gut-Brain Axis
    • Dr. Chang: How to Explain the Brain-Gut Axis, Pain Regulation and the Use of Neuromodulators
    • Dr. Drossman: How to Explain the Brain-Gut Axis and the Pathophysiology of Chronic Pain
    • Dr. Halpert: How to Explain the Brain-Gut Axis    
    • Dr. Lucak: How to Explain the Brain-Gut Axis
    • Dr. Sayuk: How to Explain the Brain-Gut Axis

Explaining the Microbiome
    • Dr. Chey: How to Explain the Microbiome
    • Dr. Simren: How to Explain the Microbiome

Patient Communication Relating to Abuse/Trauma
    • Dr. Chang: How to Facilitate Discussion of Sensitive Topics (e.g., Abuse)

Pediatric Issues
    • Dr. Nurko: How to Explain a Child's Abdominal Pain and Constipation to the Parent
    • Dr. Nurko: How to Explain to an Adolescent and Her Mother About Abdominal Pain and the Use of Neuromodulators

Explaining Peripheral Neuromodulators (Secretagogues and Prokinetics)
    • Dr. Cash: How to Explain the Use of Peripheral Neuromodulators (Secretagogues and Prokinetic Agents) for Constipation
    • Dr. Lacy: How to Explain the use of Secretagogues (Peripheral Neuromodulator) for Constipation
    • Dr. Lembo: How to Explain the Use of Prokinetics (Peripheral Neuromodulators) for Constipation


Faculty
The faculty are all key opinion leaders in Neurogastroenterology and Disorders of Gut-Brain Interaction and are certified facilitators in the DrossmanCare/Rome Foundation Communication Skills Program.

Brooks D. Cash, MD
Dr. Cash is the Chief of the Division of Gastroenterology, Hepatology, and Nutrition at the University of Texas Health Science Center at Houston, as well as a Visiting Professor of Medicine at the University of Texas McGovern Medical School. 

Lin Chang, MD
Dr. Chang is the Vice Chief, Vatche and Tamar Manoukian Division of Digestive Diseases Program Director, UCLA GI Fellowship Program Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience and Professor of Medicine at the David Geffen School of Medicine at UCLA.

William D. Chey, MD
Dr. Chey is at the University of Michigan, where he is currently a Professor of Medicine in the Division of Gastroenterology and Director of the GI Physiology Laboratory and Michigan Bowel Control Program.

Douglas A. Drossman, MD
Dr. Drossman is Professor Emeritus of Medicine and Psychiatry in Gastroenterology at the University of North Carolina School of Medicine. He is President Emeritus and Chief of Operations of the Rome Foundation. Currently, he is President of the Center for Education and Practice of Biopsychosocial Care (DrossmanCare) and Drossman Gastroenterology. 

Albena D. Halpert, MD
Dr. Halpert is an Assistant Professor of Medicine at Boston University School of Medicine and a practicing Gastroenterologist at Harvard University Student Medical Center.

Lucinda A. Harris, MD
Dr. Harris is an Associate Professor of Medicine and a Gastroenterologist and Consultant in the Division of Gastroenterology and Hepatology, Department of Internal Medicine at Mayo Clinic in Phoenix, AZ.

Laurie Keefer, PhD
Dr. Keefer is an academic health psychologist and the Director for Psychobehavioral Research within the Division of Gastroenterology. She specializes in the psychosocial care of patients with chronic digestive diseases, specifically inflammatory bowel diseases such as Crohn's or ulcerative colitis. Dr. Keefer came to Mount Sinai in January 2016 from Chicago, IL, to lead a subspecialty medical home for inflammatory bowel diseases (IBD).

Sarah Kinsinger, PhD
Dr. Kinsinger is an associate professor in the division of gastroenterology and nutrition of Loyola University Chicago Stritch School of Medicine. She has a secondary appointment in the department of psychiatry and behavioral neurosciences and specializes in the treatment of gastrointestinal disorders.

Brian Lacy, MD
Dr. Lacy is a board-certified gastroenterologist who focuses his research and clinical interests on disorders of gastrointestinal motility at the Mayo Clinic in Jacksonville, FL. Dr. Lacy is the current co-Editor in Chief of the American Journal of Gastroenterology. He is the former Editor in Chief of Clinical and Translational Gastroenterology.

Anthony J Lembo, MD
Dr. Lembo is an Associate Professor of Medicine at Harvard Medical School
and works in the Department of Medicine, Division of Gastroenterology at Beth Israel Deaconess Medical Center, Boston, MA He also serves as the Director of the GI Motility Laboratory at the Beth Israel Deaconess Medical Center (BIDMC) Division of Gastroenterology in Boston, MA. 

Susan L. Lucak, MD
Dr. Lucak is a practicing gastroenterologist at Weill Cornell Medical and an associate professor of Medicine at Weill Cornell Medical College. Dr. Lucak has focused her practice on functional gastrointestinal disorders, including irritable bowel syndrome, chronic abdominal pain, persistent diarrhea, chronic constipation, and bloating, among others.

Sam Nurko, MD, MPH
Dr. Nurko is the Director, Center for Motility and Functional Gastrointestinal Disorders, and the Director, Functional Abdominal Pain Program at Boston Children’s Hospital in Boston, MA. He is also a Professor of Pediatrics, Harvard Medical School.

Johannah Ruddy, M.Ed.
Ms. Ruddy is Executive Director of the Rome Foundation and Secretary-Treasurer of DrossmanCare. She has worked as a patient advocate and is a patient simulator for this program.

Gregory S. Sayuk, MD, MPH
Dr. Sayuk is an Associate Professor, Medicine at the Washington University School of Medicine in St Louis, MO, and Associate Professor, Psychiatry. He is a practicing gastroenterologist in the Division of Gastroenterology with a focus on Functional GI Disorders.

Magnus Simren, MD
Dr. Simren is a Professor of Gastroenterology at the University of Gothenburg, Sweden, and a Senior Consultant, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. He also serves as an Adjunct Professor of Medicine at the University of North Carolina School of Medicine. 

Jan Tack, MD, PhD
Dr. Tack is currently the Head of Clinic in the Department of Gastroenterology, and a Professor of Internal Medicine and Head of the Department of Clinical and Experimental Medicine at the University of Leuven. He is also a principal researcher in TARGID (the Translational Research Center for Gastrointestinal Disorders) at the University of Leuven in Belgium. Dr. Tack is President of the Rome Foundation.

Notice: The indications and dosages of all medications in this video program are based on information recommended by the Rome Foundation, are supported in the medical literature, and conform to the practices of the general medical community. The medications described do not necessarily have specific approval by the Food and Drug Administration or other national regulatory agencies for use in the diseases and dosages for which they are recommended. The package insert for each drug should be consulted for use and dosage as approved by the FDA. Because standards for usage change, it is advisable to keep abreast of revised recommendations, particularly those concerning new medications.
© Copyright 2020, Rome Foundation and DrossmanCare. All rights reserved.